Thrivent Financial for Lutherans’s ARK Genomic Revolution ETF ARKG Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,095	Closed	-$313K	–	2439
2022 Q4	$313K	Sell	11,095 -4,856	-30%	-$154K	﹤0.01%	2245
2022 Q3	$525K	Buy	15,951 +1,254	+9%	+$46K	﹤0.01%	2055
2022 Q2	$463K	Buy	14,697 +4,488	+44%	+$157K	﹤0.01%	2125
2022 Q1	$469K	Buy	+10,209	New	+$487K	﹤0.01%	2201
2021 Q4	–	Hold	0	–	–	–	2230
2021 Q3	–	Hold	0	–	–	–	2203
2021 Q2	–	Hold	0	–	–	–	2218
2021 Q1	–	Hold	0	–	–	–	2379
2020 Q4	–	Hold	0	–	–	–	2387

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Thrivent Financial for Lutherans's ARKG Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 11,095 shares — an estimated $313K sold.

Thrivent Financial for Lutherans first reported a position in ARKG in Q1 2022 and held it in 4 quarters. The position peaked at $525K in Q3 2022. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

Thrivent Financial for Lutherans reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
Thrivent Financial for Lutherans sold 11,095 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $313K.
Thrivent Financial for Lutherans first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 4 quarters.
Thrivent Financial for Lutherans's ARK Genomic Revolution ETF position peaked at $525K in Q3 2022.
295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.